GO:0003342 proepicardium development: Embryonic Origin, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003342 (proepicardium development) describes the progression of the proepicardium, an outpouching of the septum transversum, from its formation to its mature structure.
• The proepicardium is a transient embryonic structure that gives rise to the epicardium and contributes to coronary vessels and cardiac fibroblasts.
• Induction of the proepicardium depends on signals from adjacent tissues, including the liver bud and the sinus venosus, and involves FGF, BMP, and retinoic acid signaling.
• Asymmetric development of the proepicardium is controlled by a right-sided FGF8/Snai1 pathway in the chick embryo.
• Environmental factors such as dioxin can inhibit proepicardium and epicardium development in zebrafish, linking this process to developmental toxicity.
• Key genes and proteins studied in proepicardium development include TBX5, WT1, TBX18, GATA4, FGF8, SNAI1, and CCBE1.
Description
The proepicardium is a transient embryonic structure that arises as an outpouching of the septum transversum and serves as the origin of the epicardium and a subset of coronary vessel cells. The Gene Ontology term GO:0003342, proepicardium development, captures the biological process by which this structure forms and matures, from its initial induction to its final organization before it contributes to the developing heart. Understanding this process is essential for developmental biologists and cardiovascular researchers because defects in proepicardium formation can lead to impaired epicardium development and coronary vascular anomalies. Research over the past two decades has identified multiple signaling pathways and transcription factors that regulate proepicardium development. Studies in chick, Xenopus, zebrafish, and mouse models have revealed conserved and divergent mechanisms, including FGF, BMP, and retinoic acid signaling, as well as asymmetric cues such as the FGF8/Snai1 pathway. The proepicardium is not merely a passive precursor; it is an actively induced and patterned tissue that responds to signals from neighboring organs such as the liver bud and sinus venosus. For researchers, GO:0003342 provides a standardized framework to annotate genes and pathways involved in this process, facilitating comparative studies and functional genomics. The term is particularly relevant for investigations into congenital heart defects, coronary artery development, and the regenerative potential of epicardium-derived cells.
proepicardium development At A Glance
| GO ID | GO:0003342 |
|---|---|
| GO term | proepicardium development |
| Ontology | biological_process |
| Synonym | none |
| Major function | Formation and maturation of the proepicardium, an outpouching of the septum transversum that gives rise to the epicardium and contributes to coronary vessels |
| Related structures | Septum transversum, epicardium, sinus venosus, liver bud |
| Key signaling pathways | FGF, BMP, retinoic acid, FGF8/Snai1 asymmetric pathway |
| Model organisms | Chick, Xenopus, zebrafish, mouse |
| Disease relevance | Congenital heart defects, coronary artery anomalies, developmental toxicity |
What Is GO:0003342?
According to the Gene Ontology, GO:0003342 (proepicardium development) is defined as the progression of the proepicardium from its formation to the mature structure. The proepicardium itself is an outpouching of the septum transversum, a transient embryonic tissue that gives rise to the epicardium and contributes to coronary vessels and cardiac fibroblasts. This process encompasses the induction, outgrowth, and maturation of the proepicardium, ultimately leading to a structure that can support epicardium formation and heart development.
Why Is proepicardium development Important in Cell Biology?
Proepicardium development is a critical early step in heart formation because the proepicardium is the source of the epicardium and a subset of coronary vessel cells. Disruption of this process can lead to defective epicardium formation, impaired coronary vasculature, and congenital heart defects. Moreover, the proepicardium serves as a model for studying tissue induction, asymmetric development, and epithelial-to-mesenchymal transition, with implications for regenerative medicine and developmental toxicology.
• The proepicardium is the embryonic origin of the epicardium, which is essential for heart development and coronary vessel formation.
• Defects in proepicardium development are associated with congenital heart defects and coronary artery anomalies.
• Proepicardium development is regulated by conserved signaling pathways, including FGF, BMP, and retinoic acid, making it a model for studying tissue induction.
• Asymmetric development of the proepicardium is controlled by a right-sided FGF8/Snai1 pathway, providing insights into left-right patterning.
• Environmental toxicants such as dioxin can disrupt proepicardium and epicardium development, linking this process to developmental toxicity.
• Genes involved in proepicardium development, such as WT1 and TBX18, are also implicated in epicardium-derived regeneration and disease.
• Understanding proepicardium development can inform strategies for cardiac regeneration and repair.
• The process is conserved across vertebrates, allowing comparative studies in chick, Xenopus, zebrafish, and mouse.
• Proepicardium development involves epithelial-to-mesenchymal transition, a process relevant to cancer metastasis and fibrosis.
• Research on GO:0003342 helps annotate gene function and supports functional genomics in cardiovascular development.
What Happens During proepicardium development?
Induction of the proepicardium
In simple terms: The proepicardium starts to form when nearby tissues send signals to the septum transversum.
The proepicardium is induced by signals from adjacent tissues, including the liver bud and the sinus venosus. Studies in chick and mouse embryos have shown that FGF and BMP signaling from these tissues are critical for proepicardium induction. The induction process involves the activation of transcription factors such as WT1 and TBX5, which mark the proepicardial mesothelium. In Xenopus, similar inductive interactions have been observed, highlighting conserved mechanisms.
Outgrowth and morphogenesis
In simple terms: After induction, the proepicardium grows outward as a cluster of cells that will later spread over the heart.
Following induction, the proepicardium undergoes outgrowth and morphogenesis, forming an outpouching of the septum transversum. In the chick embryo, this outgrowth is asymmetric, with a right-sided pathway involving FGF8 and Snai1 controlling the direction and shape of the proepicardium. The proepicardium consists of a mesothelial layer that will eventually give rise to the epicardium. Cell proliferation and changes in cell shape contribute to the outgrowth process.
Asymmetric development and left-right patterning
In simple terms: The proepicardium develops differently on the left and right sides, guided by specific signals.
Asymmetric development of the proepicardium is a key feature in some species. In the chick embryo, a right-sided pathway involving FGF8 and Snai1 controls asymmetric development of the proepicardium. This asymmetry ensures proper positioning and subsequent epicardium formation. Disruption of this pathway leads to abnormal proepicardium development and downstream defects.
Maturation and fate
In simple terms: The mature proepicardium is ready to release cells that will cover the heart and form coronary vessels.
The mature proepicardium is a cluster of mesothelial cells that will eventually migrate to the heart surface and form the epicardium. From the epicardium, cells undergo epithelial-to-mesenchymal transition and contribute to coronary vessels, cardiac fibroblasts, and smooth muscle cells. The maturation of the proepicardium involves the expression of markers such as TBX18 and WT1, which are essential for its function. In zebrafish, proepicardium development is also influenced by environmental factors such as dioxin, which inhibits its formation.
Key Genes Involved in GO:0003342 proepicardium development
The following genes and proteins have been experimentally implicated in proepicardium development, based on studies in chick, Xenopus, zebrafish, and mouse models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| WT1 | Transcription factor marking proepicardial mesothelium; essential for epicardium formation | Used as a marker for proepicardium and epicardium; knockout leads to failure of epicardium formation |
| TBX5 | Transcription factor involved in proepicardium induction and heart development | Mutations cause Holt-Oram syndrome; studied in proepicardium induction |
| TBX18 | Transcription factor expressed in proepicardium and epicardium | Required for coronary vessel development; marker for proepicardial cells |
| GATA4 | Transcription factor regulating proepicardium and heart development | Implicated in congenital heart defects; regulates proepicardial gene expression |
| FGF8 | Signaling molecule in right-sided pathway controlling asymmetric proepicardium development | Studied in chick embryo for left-right asymmetry |
| SNAI1 | Transcription factor downstream of FGF8 in asymmetric proepicardium development | Involved in epithelial-to-mesenchymal transition; regulates proepicardium asymmetry |
| CCBE1 | Extracellular matrix protein involved in cardiac development and lymphangiogenesis | Mutations cause Hennekam syndrome; may affect proepicardium development |
| BMP2 | Signaling molecule involved in proepicardium induction | Studied in chick and mouse for proepicardial induction |
| BMP4 | Signaling molecule involved in proepicardium induction and epicardium formation | Knockout studies show defects in proepicardium and heart development |
| FGF2 | Signaling molecule promoting proepicardium outgrowth | Used in explant cultures to study proepicardium development |
| RAR | Retinoic acid receptor involved in proepicardium induction | Retinoic acid signaling is required for proepicardium formation |
| HAND2 | Transcription factor in proepicardium and heart development | Studied in proepicardium induction and coronary development |
| NKX2-5 | Transcription factor in heart development; may influence proepicardium | Mutations cause congenital heart defects; potential role in proepicardium |
| VEGFA | Growth factor involved in coronary vessel development from proepicardium | Studied in epicardium-derived coronary vessels |
| PDGFB | Signaling molecule in coronary vessel development | Involved in proepicardium-derived cell migration |
| SOX9 | Transcription factor in proepicardium and epicardium | Studied in epicardium formation and coronary development |
| ALDH1A2 | Enzyme for retinoic acid synthesis; involved in proepicardium induction | Retinoic acid signaling is essential for proepicardium development |
| SEMA3D | Guidance molecule for proepicardium-derived cells | Studied in coronary vessel patterning |
How Is proepicardium development Regulated?
Proepicardium development is regulated by a complex interplay of signaling pathways and transcription factors. FGF, BMP, and retinoic acid signaling from adjacent tissues such as the liver bud and sinus venosus are critical for induction. In the chick embryo, a right-sided FGF8/Snai1 pathway controls asymmetric development of the proepicardium. Additionally, environmental factors such as dioxin can disrupt proepicardium development by interfering with these signaling pathways. The process is also influenced by extracellular matrix components, including CCBE1, which is involved in cardiac development and lymphangiogenesis.
proepicardium development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| WT1 | Congenital heart defects; epicardium failure | Knockout mouse, zebrafish morpholino |
| TBX5 | Holt-Oram syndrome; heart and limb defects | Knockout mouse, patient-derived iPSCs |
| GATA4 | Congenital heart defects | Knockout mouse, zebrafish |
| CCBE1 | Hennekam syndrome; lymphatic dysplasia | Knockout zebrafish, mouse |
| FGF8 | Asymmetric proepicardium defects | Chick embryo manipulation, mouse knockout |
Congenital heart defects and coronary artery anomalies
Disruption of proepicardium development can lead to congenital heart defects, particularly those affecting the coronary vasculature. The proepicardium is the source of coronary vessel precursors, and defects in its formation or maturation can result in coronary artery anomalies. Mutations in genes such as WT1, TBX5, and GATA4, which are involved in proepicardium development, are associated with human congenital heart disease.
Developmental toxicity
Environmental toxicants such as dioxin (TCDD) inhibit proepicardium and epicardium development in zebrafish, leading to heart defects. This highlights the sensitivity of proepicardium development to environmental factors and its relevance to developmental toxicity testing.
Hennekam syndrome and lymphatic disorders
CCBE1, a gene involved in cardiac development and lymphangiogenesis, is mutated in Hennekam syndrome, a rare disorder characterized by lymphangiectasia and lymphedema. While the direct link to proepicardium development is not fully established, CCBE1 expression in the proepicardium suggests a potential role in its development.
From proepicardium development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate proepicardium induction? | Knockout mouse or zebrafish (CRISPR/Cas9) |
| What is the role of a specific point mutation in gene Y? | Point-mutation knock-in mouse or cell line |
| How does gene Z affect proepicardium outgrowth? | Overexpression in chick embryo or Xenopus |
| Where is protein X localized in proepicardium? | Tagged knock-in (e.g., GFP) in mouse or zebrafish |
| What is the transcriptional profile of proepicardium? | RNA-seq of isolated proepicardium from wild-type and mutant embryos |
| How does environmental toxin affect proepicardium? | Zebrafish embryo exposed to dioxin |
How to Study the proepicardium development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Confocal microscopy | Morphology and protein localization | Visualizing proepicardium structure in embryos |
| Lineage tracing | Cell fate and migration | Tracking proepicardium-derived cells |
| RNA-seq | Transcriptional profile | Identifying genes expressed in proepicardium |
| Single-cell RNA-seq | Cell heterogeneity | Characterizing proepicardial cell subtypes |
| CRISPR/Cas9 knockout | Gene function | Testing candidate genes in zebrafish/mouse |
| In situ hybridization | mRNA localization | Detecting proepicardial markers |
| Explant culture | Signaling requirements | Studying induction in chick embryos |
Imaging and lineage tracing
Confocal microscopy and lineage tracing using fluorescent reporters (e.g., WT1-GFP) allow visualization of proepicardium development in real time. In chick and Xenopus embryos, explant cultures and dye labeling have been used to study proepicardium outgrowth.
Transcriptomics and single-cell RNA sequencing
RNA-seq of isolated proepicardium or single-cell RNA-seq can identify genes and pathways active during proepicardium development. This approach has been used to characterize proepicardial cell populations and their differentiation trajectories.
Genetic manipulation in model organisms
CRISPR/Cas9 knockout, knock-in, and overexpression in zebrafish, mouse, and chick embryos are powerful methods to test gene function in proepicardium development. Morpholino knockdown in Xenopus and zebrafish has also been used.
Pharmacological and toxicological assays
Exposure of zebrafish embryos to dioxin and other chemicals can assess the impact of environmental factors on proepicardium development. Small molecule inhibitors of FGF, BMP, and retinoic acid signaling can be used in explant cultures.
How CRISPR Can Be Used to Study GO:0003342 proepicardium development
Knockout
CRISPR/Cas9 knockout of candidate genes in zebrafish or mouse is used to determine their requirement for proepicardium development. For example, knockout of wt1 or tbx18 leads to failure of epicardium formation, demonstrating the essential role of these genes. Knockout models can be analyzed by in situ hybridization for proepicardial markers.
Point Mutation
Point mutations identified in human congenital heart disease patients can be introduced into model organisms using CRISPR/Cas9 to study their impact on proepicardium development. For instance, specific mutations in TBX5 or GATA4 can be modeled in zebrafish or mouse to assess effects on proepicardial induction.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous loci such as WT1 or TBX18 allows live imaging of proepicardium development. This approach enables tracking of proepicardial cell migration and differentiation in real time.
Overexpression
Overexpression of signaling molecules such as FGF8 or SNAI1 in chick embryos using retroviral vectors or electroporation can test their sufficiency to induce or alter proepicardium development. In zebrafish, heat-shock inducible overexpression can be used to temporally control gene activity.
How EDITGENE Supports proepicardium development Research
Researchers studying proepicardium development-related genes often need to determine whether a candidate gene is causally involved in the process, and to dissect its precise function using targeted genetic models. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for proepicardium development research.
Frequently Asked Questions About proepicardium development
What is GO:0003342?
GO:0003342 is the Gene Ontology term for proepicardium development, defined as the progression of the proepicardium from its formation to the mature structure. The proepicardium is an outpouching of the septum transversum.
What is the proepicardium?
The proepicardium is a transient embryonic structure that arises from the septum transversum and gives rise to the epicardium and a subset of coronary vessel cells.
What genes are involved in proepicardium development?
Key genes include WT1, TBX5, TBX18, GATA4, FGF8, SNAI1, and CCBE1, among others.
How is proepicardium development regulated?
It is regulated by FGF, BMP, and retinoic acid signaling, as well as asymmetric cues such as the FGF8/Snai1 pathway.
What model organisms are used to study proepicardium development?
Chick, Xenopus, zebrafish, and mouse are commonly used models.
What diseases are associated with defects in proepicardium development?
Defects can lead to congenital heart defects, coronary artery anomalies, and developmental toxicity.
How can CRISPR be used to study proepicardium development?
CRISPR can create knockout, point mutation, knock-in, and overexpression models in zebrafish, mouse, and cell lines to test gene function.
What is the role of WT1 in proepicardium development?
WT1 is a transcription factor that marks the proepicardial mesothelium and is essential for epicardium formation.
What is the FGF8/Snai1 pathway in proepicardium development?
It is a right-sided signaling pathway in the chick embryo that controls asymmetric development of the proepicardium.
How does dioxin affect proepicardium development?
Dioxin inhibits zebrafish epicardium and proepicardium development, linking environmental toxicants to heart defects.
Conclusion
GO:0003342 (proepicardium development) is a fundamental biological process that underpins the formation of the epicardium and coronary vasculature. Research across multiple model organisms has elucidated key signaling pathways and transcription factors, providing insights into congenital heart defects and developmental toxicity. Continued investigation using advanced genetic tools, including CRISPR-based models, will further unravel the molecular mechanisms and translational potential of this process.
References
- 1. Ratajska A et al.. 2008. Embryonic development of the proepicardium and coronary vessels.. Int J Dev Biol 52(2-3):229-36 PMID: 18311713
- 2. Niderla-BieliŃska J et al.. 2019. Proepicardium: Current Understanding of its Structure, Induction, and Fate.. Anat Rec (Hoboken) 302(6):893-903 PMID: 30421563
- 3. Jahr M et al.. 2008. Development of the proepicardium in Xenopus laevis.. Dev Dyn 237(10):3088-96 PMID: 18816844
- 4. Maya-Ramos L et al.. 2013. Induction of the Proepicardium.. J Dev Biol 1(2):82-91 PMID: 23956959
- 5. Bonet F et al.. 2022. CCBE1 in Cardiac Development and Disease.. Front Genet 13:836694 PMID: 35222551
- 6. Plavicki J et al.. 2013. Dioxin inhibits zebrafish epicardium and proepicardium development.. Toxicol Sci 131(2):558-67 PMID: 23135548
- 7. Schlueter J et al.. 2009. A right-sided pathway involving FGF8/Snai1 controls asymmetric development of the proepicardium in the chick embryo.. Proc Natl Acad Sci U S A 106(18):7485-90 PMID: 19365073
- 8. He L et al.. 2018. The Development and Regeneration of Coronary Arteries.. Curr Cardiol Rep 20(7):54 PMID: 29802591
